Expanded Access for Iberdomide

Sponsor
Bristol-Myers Squibb
Study ID
NCT07434960
Status
Available

Eligibility Criteria

Sex
All
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

This is an expanded access designed to provide access to Iberdomide for eligible participants.

Key Dates

First listed
Feb 27, 2026
Status verified
Feb 2026

Central Contacts

  • BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
    855-907-3286
    [email protected]
  • First line of the email MUST contain the NCT# and Site #.